Andy Porter - 28 Oct 2022 Form 4 Insider Report for Relay Therapeutics, Inc. (RLAY)

Role
Chief Administrative Officer
Signature
/s/ Brian Adams, as attorney-in-fact
Issuer symbol
RLAY
Transactions as of
28 Oct 2022
Net transactions value
-$9,650
Form type
4
Filing time
01 Nov 2022, 18:03:13 UTC
Previous filing
29 Sep 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RLAY Common Stock Sale $9,650 -448 -0.98% $21.54 45,164 28 Oct 2022 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Sale of shares to cover the reporting person's income tax withholding obligations upon the vesting of 1,510 shares of restricted stock units ("RSUs") on October 27, 2022. The reporting person had no discretion with respect to such sale, which was transacted in accordance with the Issuer's policies regarding the vesting of RSUs.
F2 Includes 28,389 shares underlying RSUs.